hepatitis c virus

Showing 1 - 25 of 95

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Seroconversion of Hepatitis c Virus Among CKD on Regular

Not yet recruiting
  • Hepatitis C Virus
    • (no location specified)
    Oct 25, 2023

    Hepatitis C Virus Trial (Dried blood spot testing)

    Not yet recruiting
    • Hepatitis C Virus
    • Dried blood spot testing
    • (no location specified)
    Mar 5, 2023

    Sovaldi in Chronic Hepatitis C Virus (HCV) Infection in Korea

    Completed
    • Hepatitis C Virus
    • Wonju, Gangwon-do, Korea, Republic of
    • +71 more
    Dec 23, 2021

    Resistance to AbbVie's 2 Direct-acting Antiviral Agent Therapy

    Completed
    • Hepatitis C Virus
      • Nagoya-shi, Aichi, Japan
      • +52 more
      Dec 6, 2021

      Harvoni in Chronic Hepatitis C Virus (HCV) Infection in Korea

      Completed
      • Hepatitis C Virus
      • Seongnam-si, Gyeonggido, Korea, Republic of
      • +71 more
      Nov 24, 2021

      Hepatitis C Virus Trial in Aurora (ribavirin)

      Completed
      • Hepatitis C Virus
      • Aurora, Colorado
        University of Colorado Denver
      Aug 20, 2021

      Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

      Completed
      • Hepatitis C Virus
      • (no location specified)
      Jul 28, 2021

      Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

      Completed
      • Chronic Hepatitis C
      • Hepatitis C Virus
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

      Completed
      • Chronic Hepatitis C Virus
      • Hepatitis C Virus
      • (no location specified)
      Jul 14, 2021

      Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)

      Completed
      • Chronic Hepatitis C Virus
      • Hepatitis C Virus
      • (no location specified)
      Jul 14, 2021

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

      Completed
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

      Completed
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Hepatitis C Virus Trial (ABT-493/ABT-530)

      Completed
      • Hepatitis C Virus
      • (no location specified)
      Jul 9, 2021

      Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

      Completed
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Hepatitis C Virus Trial in New Zealand, United States (Velpatasvir)

      Completed
      • Hepatitis C Virus
      • Miami, Florida
      • +4 more
      Oct 20, 2020

      Hepatitis C Virus Trial in Worldwide (Pegylated-Interferon-lambda, Ribavirin, Daclatasvir)

      Completed
      • Hepatitis C Virus
      • Pegylated-Interferon-lambda
      • +2 more
      • Palo Alto, California
      • +31 more
      Aug 7, 2020

      Hepatitis C Virus Trial (Paritaprevir, Ritonavir, Dasabuvir)

      Unknown status
      • Hepatitis C Virus
      • (no location specified)
      Oct 4, 2019

      Hepatitis C Virus Trial in Worldwide (Peginterferon Lambda-1a, Peginterferon Alfa-2a, Ribavirin)

      Completed
      • Hepatitis C Virus
      • Peginterferon Lambda-1a
      • +3 more
      • Birmingham, Alabama
      • +103 more
      Jul 29, 2019

      Strategy for Hepatitis C in Ukraine

      Completed
      • Hepatitis C Virus
      • Sofosbuvir/ledipasvir (SOF/LDV)
      • Kiev, Ukraine
      • +1 more
      Jul 28, 2019

      IFNL4 Genotype for Predicting Response to Ledipasvir/Sofosbuvir

      Withdrawn
      • Hepatitis C Virus
        • (no location specified)
        Jul 8, 2019

        Hepatitis C Virus, HIV Trial in Worldwide (LDV/SOF, RBV)

        Completed
        • Hepatitis C Virus
        • HIV
        • Birmingham, Alabama
        • +40 more
        Oct 19, 2018